Clinical Trial Update: Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 randomized double-blind placebo-controlled study in overweight and obese subjects evaluating weight loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Certmedica International GmbH | Conditions: Weight Loss | Phase 4 | Status: COMPLETED